CompletedNot Applicable

Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy

South Korea24 participantsStarted 2008-03

Plain-language summary

This study is a comparison of multifocal electroretinogram assessment between the laser treatment group and the photodynamic therapy group in chronic central serous chorioretinopathy.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. CSC (over 3 months) when subretinal fluid persisted in the subfoveal region demonstrated by clinical examination and OCT
✓. Ability to maintain steady fixation for mfERG
✓. Presence of abnormal dilated choroidal vasculature in ICGA
✓. Symptom duration over 3 months

Exclusion criteria

✕. Previous PDT or laser treatment history
✕. Evidence of CNV in FAG
✕. Other chorioretinal disorders that can cause macular exudation such as age-related macular degeneration, pathologic myopia, angioid streaks, trauma, inflammatory diseases, retinal vasculopathies, and hereditary dystrophies

What they're measuring

Multifocal Electroretinogram Amplitudes

Timeframe: baseline, 1 month, 3 months, 6 months

Trial details

NCT IDNCT00803517

SponsorSamsung Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2008-10

Results submitted2008-11-12

View on ClinicalTrials.gov More Central Serous Chorioretinopathy trials